Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Moulder

Showing results (41-50 of 164) with videos related to

Pageof 17
Sort By:
Cancer Communications|May 1, 1991
Prediction of tumor radiosensitivity by hexafluoromisonidazole retention monitored by [1H]/[19F] magnetic resonance spectroscopyS J Li, G Y Jin, J E Moulder
International Journal of Radiation Oncology, Biology, Physics|September 1, 1993
Treatment of radiation nephropathy with ACE inhibitorsJ E Moulder, B L Fish, E P Cohen
The British Journal of Cancer. Supplement|June 1, 1978
Effect of combined metronidazole and DMSO on tumour control and skin tolerance in the ratJ E Moulder, P S Lo, J J Fischer
Radiation Research|December 1, 1992
Treatment of radiation nephropathy with captoprilE P Cohen, B L Fish, J E Moulder
Investigative Ophthalmology & Visual Science|April 1, 1986
The immune system in experimental Pseudomonas keratitis. Model and early effectsS S Twining, K M Lohr, J E Moulder
Radiation Research|November 7, 1998
Brief pharmacological intervention in experimental radiation nephropathyJ E Moulder, B L Fish, E P Cohen
Current Pharmaceutical Design|May 18, 2007
Treatment of radiation nephropathy with ACE inhibitors and AII type-1 and type-2 receptor antagonistsJ E Moulder, B L Fish, E P Cohen
International Journal of Radiation Biology|July 4, 2014
Mitigation of experimental radiation nephropathy by renin-equivalent doses of angiotensin converting enzyme inhibitorsJohn E Moulder, Eric P Cohen, Brian L Fish
International Journal of Radiation Biology|May 20, 1998
Angiotensin II receptor antagonists in the treatment and prevention of radiation nephropathyJ E Moulder, B L Fish, E P Cohen
Cancer|February 1, 1982
Fatal misonidazole-induced encephalopathy: an RTOG case reportL E Kun, K C Ho, J E Moulder
Pageof 17

Showing results (41-50 of 164) with videos related to

Sort By:
Pageof 17
Cancer Communications|May 1, 1991
Prediction of tumor radiosensitivity by hexafluoromisonidazole retention monitored by [1H]/[19F] magnetic resonance spectroscopyS J Li, G Y Jin, J E Moulder
International Journal of Radiation Oncology, Biology, Physics|September 1, 1993
Treatment of radiation nephropathy with ACE inhibitorsJ E Moulder, B L Fish, E P Cohen
The British Journal of Cancer. Supplement|June 1, 1978
Effect of combined metronidazole and DMSO on tumour control and skin tolerance in the ratJ E Moulder, P S Lo, J J Fischer
Radiation Research|December 1, 1992
Treatment of radiation nephropathy with captoprilE P Cohen, B L Fish, J E Moulder
Investigative Ophthalmology & Visual Science|April 1, 1986
The immune system in experimental Pseudomonas keratitis. Model and early effectsS S Twining, K M Lohr, J E Moulder
Radiation Research|November 7, 1998
Brief pharmacological intervention in experimental radiation nephropathyJ E Moulder, B L Fish, E P Cohen
Current Pharmaceutical Design|May 18, 2007
Treatment of radiation nephropathy with ACE inhibitors and AII type-1 and type-2 receptor antagonistsJ E Moulder, B L Fish, E P Cohen
International Journal of Radiation Biology|July 4, 2014
Mitigation of experimental radiation nephropathy by renin-equivalent doses of angiotensin converting enzyme inhibitorsJohn E Moulder, Eric P Cohen, Brian L Fish
International Journal of Radiation Biology|May 20, 1998
Angiotensin II receptor antagonists in the treatment and prevention of radiation nephropathyJ E Moulder, B L Fish, E P Cohen
Cancer|February 1, 1982
Fatal misonidazole-induced encephalopathy: an RTOG case reportL E Kun, K C Ho, J E Moulder
Pageof 17